Efficacy and safety of initial combined therapy with metformin plus a dipeptidyl peptidase-4 inhibitor versus metformin monotherapy in type 2 diabetes mellitus: a systematic review and meta-analysis of phase 3 randomised controlled trials

Timothy O'Brien

Efficacy and safety of initial combined therapy with metformin plus a dipeptidyl peptidase-4 inhibitor versus metformin monotherapy in type 2 diabetes mellitus: a systematic review and meta-analysis of phase 3 randomised controlled trials

Medicine

Research output: Other contribution (Published) › Other contribution

Original language	English (Ireland)
Media of output	Other Item
Volume	188
Publication status	Published - 1 Oct 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{f21b6a5dbc9241fa952a897a4d54b94b,

title = "Efficacy and safety of initial combined therapy with metformin plus a dipeptidyl peptidase-4 inhibitor versus metformin monotherapy in type 2 diabetes mellitus: a systematic review and meta-analysis of phase 3 randomised controlled trials",

author = "Timothy O'Brien",

year = "2019",

month = oct,

day = "1",

language = "English (Ireland)",

volume = "188",

type = "Other",

}